American scientists found inhaling xenon boosted brain health and improved problem-solving skills, which could potentially ...

And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...

In a new study published in The BMJ, we and our colleagues Vishal Patel and Michael Liu, also at Harvard, set out to study rates of Alzheimer’s deaths among taxi drivers and ambulance drivers, who ...

"Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades, with ...

By 2060, 1 million adults per year will develop dementia, according to a study published in Nature Medicine. Also in the news, chronic cannabis use may lead to chronic illness; Eli Lilly hopes to ...

The lifetime risk of dementia after age 55 is about 42% - more than double the risk reported by earlier studies, and one that puts greater urgency on the need to mitigate addressable health problems, ...

Dementia cases are expected to more than double in the coming decades, with the risk beginning as early as 55, and the ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

Am I a doomed man? When I was 25, I survived a battle with testicular cancer. The good news is that 45 years later, after two ...